Dr. Bryan W. Kluck, D.O.
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- Philadelphia College of Osteopathic Medicine (1981)
- Years since graduation
- 45
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 104
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1981Medical school: Philadelphia College of Osteopathic Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
PA license OS005012L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Advanced Limb Salvage Center LLC (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 104
- Services billed
- 198
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 82 | 81 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 57 | 43 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 53 | 53 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 21 | 15 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 20 | 20 |
| Established patient office or other outpatient visit, 40-54 minutes | 13 | 13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 11 companies reported 16 payments worth $331 in total to this clinician.
| Tactile Systems Technology Inc | $50.92 |
|---|---|
| Amgen Inc. | $49.65 |
| Esperion Therapeutics, Inc. | $39.25 |
| Novartis Pharmaceuticals Corporation | $39.24 |
| Biotronik Inc. | $28.71 |
| Actelion Pharmaceuticals US, Inc. | $24.42 |
| Abbott Laboratories | $23.32 |
| Merck Sharp & Dohme LLC | $22.34 |
| Food and Beverage | $331 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $500 in research payments for these studies, mostly to the institutions running them.
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
W. L. Gore & Associates, Inc. · Recruiting · NCT03821129
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.